Cargando…

Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most prevalent malignant tumors with poor prognosis. Increasing evidence has revealed that immune cells and checkpoints in the tumor microenvironment (TME) and aging are associated with the prognosis of HCC. However, the association between ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Dong, Zhao, Zhibo, Hu, Jiejun, Dai, Xin, Zhong, Guochao, Gong, Jianping, Qi, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980463/ https://www.ncbi.nlm.nih.gov/pubmed/35392063 http://dx.doi.org/10.3389/fsurg.2022.836080

Ejemplares similares

Identification of a Prognostic Model Based on 2-Gene Signature and Analysis of Corresponding Tumor Microenvironment in Alcohol-Related Hepatocellular Carcinoma
por: Guo, Yong, et al.
Publicado: (2021)

Identification of Mutator-Derived Alternative Splicing Signatures of Genomic Instability for Improving the Clinical Outcome of Cholangiocarcinoma
por: Lin, Zijing, et al.
Publicado: (2021)

GATA3 Predicts the Tumor Microenvironment Phenotypes and Molecular Subtypes for Bladder Carcinoma
por: Zhang, Qixin, et al.
Publicado: (2022)

Classification of the mitochondrial ribosomal protein-associated molecular subtypes and identified a serological diagnostic biomarker in hepatocellular carcinoma
por: Xie, Cong, et al.
Publicado: (2023)

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
por: Hu, Jiejun, et al.
Publicado: (2021)

Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021)

Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection
por: Zhou, Qian, et al.
Publicado: (2023)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer
por: Wang, Beibei, et al.
Publicado: (2023)

Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma
por: Gan, Yuling, et al.
Publicado: (2022)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Prognostic model of immune-related genes for patients with hepatocellular carcinoma
por: Cai, Qun, et al.
Publicado: (2022)

Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model
por: Nie, Shiwen, et al.
Publicado: (2022)

E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma
por: Tan, Zhibo, et al.
Publicado: (2022)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
por: Gu, Xiangqian, et al.
Publicado: (2022)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment
por: Jiang, Zhongyi, et al.
Publicado: (2021)

ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

CYP1B1: A Novel Molecular Biomarker Predicts Molecular Subtype, Tumor Microenvironment, and Immune Response in 33 Cancers
por: Yuan, Benchao, et al.
Publicado: (2022)

THEM6: A Novel Molecular Biomarker Predicts Tumor Microenvironment, Molecular Subtype, and Prognosis in Bladder Cancer
por: Zhao, Xu, et al.
Publicado: (2022)

Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer
por: Wu, Li-Hong, et al.
Publicado: (2023)

Dynamic risk prediction models for different subtypes of hypertensive disorders in pregnancy
por: Zhang, Xinyu, et al.
Publicado: (2022)

Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
por: Xu, Fangshi, et al.
Publicado: (2023)

Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment
por: Tan, Wei, et al.
Publicado: (2022)

Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol
por: Huang, Jun Tao, et al.
Publicado: (2023)

Development and Validation of a Novel Hypoxia Score for Predicting Prognosis and Immune Microenvironment in Rectal Cancer
por: Yang, Kaiyan, et al.
Publicado: (2022)

Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis
por: Liang, Xiangdong, et al.
Publicado: (2022)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
por: Lin, Hongsheng, et al.
Publicado: (2021)

Identification of Ferroptosis‐related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy
por: Long, Shichao, et al.
Publicado: (2022)

Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment
por: Wang, Jukun, et al.
Publicado: (2021)

Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma
por: Yu, Shanshan, et al.
Publicado: (2021)

Editorial: Efficacy, safety and biomarkers of novel therapeutics and regimens in the peri-operative setting of bone and soft tissue sarcoma
por: Bao, Qiyuan
Publicado: (2023)

Immune Microenvironment in Glioblastoma Subtypes
por: Chen, Zhihong, et al.
Publicado: (2018)

Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making
por: Qiang, Sufeng, et al.
Publicado: (2022)

External validation and improvement of the scoring system for predicting the prognosis in hepatocellular carcinoma after interventional therapy
por: Qiao, Wenying, et al.
Publicado: (2023)

Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer
por: Wang, Xinjing, et al.
Publicado: (2021)

Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune Microenvironment
por: Ding, Ran, et al.
Publicado: (2023)

Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment
por: Xu, Zhengjie, et al.
Publicado: (2021)

Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
por: Wang, Xiaoqiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nkungv2n9oeenc5eafod7ltri4